AI May Kill Us All. But Biotech Is the Bigger Threat to Stocks | Cabot Street Check

This week on Street Check, Chris and Brad discuss the recent strength in biotech stocks, the Fed’s rate hike, Warsh’s credibility, and what the Summary of Economic Projections (SEP) tells us about rates going forward. Then, they debate recent fear-mongering by AI companies, whether AI will “kill us all,” and what it could mean for investors. To close out the episode, Mike Cintolo joins to share his insights on the state of the market, growth stocks, and his optimism about the months ahead. For more information on this week’s offer, visit cabotwealth.com/street.